Q3 2019 Holdings
Filed 2019-11-13 | 14 holdings | $19.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $19.7M | 204,088 | 98.8% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $45.2K | 2,350,477 | 0.2% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $45.1K | 2,393,612 | 0.2% |
| Blueprint Medicines Corporation(2L9) | COM | 09627Y109 | $41.1K | 559,381 | 0.2% |
| Immunomedics, Inc.(IMMU) | COM | 452907108 | $25.9K | 1,956,362 | 0.1% |
| Myokardia, Inc. | COM | 62857M105 | $15.6K | 298,666 | 0.1% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $12.8K | 611,893 | 0.1% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $10.3K | 998,278 | 0.1% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $10.1K | 254,923 | 0.1% |
| Natera, Inc.(NTRA) | COM | 632307104 | $9.4K | 286,468 | 0.0% |
| Audentes Therapeutics, Inc.(BOLDEUR) | COM | 05070R104 | $8.9K | 315,331 | 0.0% |
| Replimune Group, Inc.(REPL) | COM | 76029N106 | $7.9K | 569,662 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $7.7K | 1,508,091 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd.(BHVN) | COM | G11196105 | $2.2K | 53,345 | 0.0% |